Mona Foth
机构: Huntsman Cancer Institute, Salt Lake City, UT, USA
每年引用次数
引用次数
引用: 1,802
H-指数: 10
I10-指数 : 11
出版物: 30
Abstract IA25: Targeting MEK1/2 inhibitor resistance in RAS-mutated cancers
Martin McMahon , Jonathan Whisenant , Lance Burrell , Soledad Camolotto
Cancer Research 80
2020
Abstract A45: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
Bryan E. Welm , Alana L. Welm , Jeffrey T. Yap , Eric L. Snyder
Molecular Cancer Research 18
2020
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
Jasper Wouters , Miguel Vizoso , Anna Martinez-Cardus , F. Javier Carmona
BMC Medicine 15 ( 1) 101 -101
34
2017
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Conan G. Kinsey , Soledad A. Camolotto , Amelie M. Boespflug , Katrin P. Guillen
Nature Medicine 25 ( 4) 620 -627
184
2019
Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice
Mona Foth , Imran Ahmad , Bas WG van Rhijn , Theodorus van der Kwast
The Journal of Pathology 233 ( 2) 148 -158
17
2014
CXCR2 inhibition suppresses acute and chronic pancreatic inflammation
Colin W Steele , Saadia A Karim , Mona Foth , Loveena Rishi
The Journal of Pathology 237 ( 1) 85 -97
41
2015
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
Mona Foth , Nur Faezah Binti Ismail , Jeng Sum Charmaine Kung , Darren Tomlinson
The Journal of Pathology 246 ( 3) 331 -343
12
2018
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele , Saadia A. Karim , Joshua D.G. Leach , Peter Bailey
Cancer Cell 29 ( 6) 832 -845
338
2016
Prognostic and predictive biomarkers in melanoma: an update
Mona Foth , Jasper Wouters , Ciaran de Chaumont , Peter Dynoodt
Expert Review of Molecular Diagnostics 16 ( 2) 223 -237
18
2016
A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis
Virginie Olive , Erich Sabio , Margaux J Bennett , Caitlin S De Jong
eLife 2 ( 2)
65
2013
RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.
Mona Foth , Gennie Parkman , Benjamin Battistone , Martin McMahon
Pigment Cell & Melanoma Research 33 ( 5) 719 -730
2020
Therapeutic targeting of autophagy in pancreatic cancer
Mona Foth , Ignacio Garrido-Laguna , Conan G Kinsey
Surgical Oncology Clinics 30 ( 4) 709 -718
4
2021
Autophagy inhibition in BRAF-driven cancers
Mona Foth , Martin McMahon
Cancers 13 ( 14) 3498 -3498
17
2021
The role of PI3'‐lipid signalling in melanoma initiation, progression and maintenance
Gennie L Parkman , Mona Foth , David A Kircher , Sheri L Holmen
Experimental dermatology 31 ( 1) 43 -56
8
2022
Genetic silencing of AKT induces melanoma cell death via mTOR suppression
Gennie L Parkman , Tursun Turapov , David A Kircher , William J Burnett
Molecular Cancer Therapeutics 23 ( 3) 301 -315
1
2024
Genetic silencing of AKT induces melanoma cell death
Gennie L Parkman , Tursun Turapov , David A Kircher , William J Burnett
bioRxiv 2022.08. 15.504039 -2022.08. 15.504039
1
2022
Newer generation mTOR inhibition represents effective therapeutic strategy for BRAF-mutant melanoma
Gennie L Parkman , Tursun Turapov , David Kircher , William Burnett
Cancer Research 83 ( 7_Supplement) 427 -427
2023
Targeting MEK1/2 inhibitor resistance in RAS-mutated cancers.
Conan Kinsey , Soledad Camolotto , Amelie Boespflug , Katrin Gullien
CANCER RESEARCH 80 ( 19) 23 -23
2020
Co-inhibition of autophagy and MAPK signaling in RAS-driven cancers
Mona Foth , Conan Kinsey , Sophia Schuman , Benjamin Battistone
Cancer Research 80 ( 16_Supplement) 1225 -1225
2020
Protective autophagy elicited by RAF-> MEK-> ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Conan G Kinsey , Soledad A Camolotto , Amelie M Boespflug , Katrin P Gullien
MOLECULAR CANCER RESEARCH 18 ( 5) 52 -53
2020